(2S,4R)-1-[(2S)-3,3-dimethyl-2-[[2-[2-[2-[4-[propyl-[(2R)-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzoyl]amino]propyl]amino]butoxy]ethoxy]ethoxy]acetyl]amino]butanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide

InChIKey	`LNVXIMZTYRLPDR-UYNIEJFQSA-N`
Compound Name	(2S,4R)-1-[(2S)-3,3-dimethyl-2-[[2-[2-[2-[4-[propyl-[(2R)-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzoyl]amino]propyl]amino]butoxy]ethoxy]ethoxy]acetyl]amino]butanoyl]-4-hydroxy-N-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]pyrrolidine-2-carboxamide
Canonical SMILES	`CCCN(CCCCOCCOCCOCC(=O)N[C@H](C(=O)N1C[C@H](O)C[C@H]1C(=O)NCc1ccc(-c2scnc2C)cc1)C(C)(C)C)C[C@@H](C)NC(=O)c1ccc(-c2noc(C(F)(F)F)n2)cc1`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	4
Pfam Stratification	Homologous
Avg pChEMBL	6.86
Source	ChEMBL

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P56524	HDAC4	Homo sapiens	Human	PF12203 PF00850	7.0	IC50	ChEMBL
Q9UKV0	HDAC9	Homo sapiens	Human	PF12203 PF00850	6.9	IC50	ChEMBL
Q9UQL6	HDAC5	Homo sapiens	Human	PF12203 PF00850	6.8	IC50	ChEMBL
Q8WUI4	HDAC7	Homo sapiens	Human	PF00850	6.7	IC50	ChEMBL